Interim
Report
on 2020
Operations
January - September 2020
Interim report on operations
at
30 September 2020
GVS Group
1
CONTENTS | ||
INFORMATION ABOUT THE COMPANY AND INFORMATION FOR SHAREHOLDERS................. | 3 | |
GROUP STRUCTURE* ...................................................................................................................................... | 4 | |
CORPORATE BODIES....................................................................................................................................... | 5 | |
DIRECTORS' REPORT ON OPERATIONS.................................................................................................... | 6 | |
Foreword ............................................................................................................................................................... | 6 | |
Group performance and analysis of the results for the period ending on 30 September 2020. ..................... | 6 | |
Investments. ........................................................................................................................................................ | 12 | |
Research and development. ............................................................................................................................... | 12 | |
Significant events occurring during the period. ............................................................................................... | 12 | |
Events subsequent to the close of the period .................................................................................................... | 13 | |
Business outlook.................................................................................................................................................. | 13 | |
FINANCIAL STATEMENTS AT 30 SEPTEMBER 2020 ............................................................................. | 15 | |
Consolidated statement of assets and liabilities* ............................................................................................. | 15 | |
Consolidated income statement* ....................................................................................................................... | 16 | |
Comprehensive consolidated income statement............................................................................................... | 17 | |
Prospectus of changes in consolidated shareholders' equity........................................................................... | 18 | |
Consolidated statement of cash flows*.............................................................................................................. | 19 | |
EXPLANATORY NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS | ||
AT 30 SEPTEMBER 2020 ................................................................................................................................. | 20 | |
1. | General information ..................................................................................................................................... | 20 |
2. | Structure and content of the consolidated financial statements ............................................................... | 20 |
3. | Valuation criteria .......................................................................................................................................... | 23 |
4. | Estimates and assumptions .......................................................................................................................... | 23 |
5. | Business combinations .................................................................................................................................. | 24 |
6. | Explanatory Notes to the main consolidated income statement items...................................................... | 26 |
7. | Non-recurring revenues and operating costs.............................................................................................. | 30 |
8. | Additional information ................................................................................................................................. | 30 |
ATTACHED TABLES ....................................................................................................................................... | 31 | |
Consolidated statement of financial position, with indication of the amounts of positions | ||
with related parties. ............................................................................................................................................ | 31 | |
Consolidated income statement, with indication of the amounts of positions with related parties. ............ | 32 | |
Consolidated statement of cash flows, with indication of the amounts of positions with related parties.... | 33 | |
Consolidated income statement, with indication of the amounts deriving from non-recurring | ||
transactions. ........................................................................................................................................................ | 34 | |
DECLARATION OF THE MANAGER RESPONSIBLE FOR THE PREPARATION | ||
OF THE COMPANY'S ACCOUNTING DOCUMENTS PURSUANT TO ARTICLE 154-BIS | ||
PARAGRAPH 2 OF LEGISLATIVE DECREE 58/98 ................................................................................... | 35 |
2
INFORMATION ABOUT THE COMPANY AND INFORMATION FOR SHAREHOLDERS
REGISTERED OFFICE
GVS S.p.A.
Via Roma 50
40069 Zola Predosa
BOLOGNA, ITALY
Phone +39 (051) 617-6311
Fax + 39 (051) 617-6200
www.gvs.com
LEGAL INFORMATION
Share capital: Euro 1,750,000
Tax code 03636630372
VAT number 00644831208
REA of Bologna 0305386
Register of Companies of Bologna 45539
INVESTOR RELATIONS
E-mail: investorrelations@gvs.com
3
GROUP STRUCTURE*
*For information on the company name, registered office, the currency in which the Company operates, share capital of the GVS Group companies and the stake held by GVS SpA, please see the Explanatory Notes.
4
CORPORATE BODIES
Board of Directors | |
Chair | Grazia Valentini (2) |
Chief Executive Officer | Massimo Scagliarini |
Executive Directors | Marco Scagliarini |
Mario Saccone | |
Matteo Viola | |
Independent Directors | Nadia Buttignol (1) |
Arabella Caporello (1) | |
Alessandro Nasi (2) | |
Michela Schizzi (1) (2) | |
Board of Statutory Auditors | |
Chair | Patrizia Lucia Maria Riva |
Standing auditors | Francesca Sandrolini |
Stefania Grazia | |
Substitute auditors | Daniela Baesi |
Mario Difino | |
Manager responsible for the preparation | |
of the company's accounting documents | Emanuele Stanco |
Independent auditors | PricewaterhouseCoopers SpA |
- Member of the Control, Risk and Sustainability Committee
- Member of the Nominations and Remuneration Committee
5
DIRECTORS' REPORT ON OPERATIONS
Foreword
The Interim Report on Operations of GVS SpA (hereinafter " GVS", the " Company", or the " Parent Company" and together with its subsidiaries the " GVS Group" or the " Group") is presented together with the interim consolidated financial statements at 30 September 2020.
The Interim Report on Operations is intended to provide information on the situation of the GVS Group and on operations as a whole and in the various sectors in which it operates, including through subsidiaries.
The tables below have been prepared on the basis of the consolidated financial statements at 30 September 2020, to which reference should be made. The latter were prepared in accordance with the International Financial Reporting Standards ("IFRS" ) issued by the International Accounting Standards Board ("IASB") and approved by the European Union, as well as with measures issued in implementation of Article 9 of Legislative Decree no. 38/2005.
Group performance and analysis of the results for the period ending on 30 September 2020.
The GVS Group is one of the world's leading suppliers of filter solutions for applications in the following industries: Healthcare & Life Sciences, Energy & Mobility and Health & Safety.
The table below breaks down revenues from contracts with customers by division in the periods ending on 30 September 2019 and 2020.
(in thousands of Euro) | Period ending on 30 September | ||
2019 | |||
2020 | |||
Healthcare Liquid | 56,991 | 51,408 | |
Healthcare Air & Gas | 42,589 | 20,175 | |
Laboratory | 15,818 | 15,058 | |
Healthcare & Lifesciences | 115,398 | 86,640 | |
Powertrain & Drivetrain | 20,216 | 31,932 | |
Safety & Electronics | 14,073 | 16,484 | |
Sport & Utility | 12,962 | 19,455 | |
Energy & Mobility | 47,250 | 67,871 | |
Personal Safety | 90,864 | 10,825 | |
Air Safety | 4,658 | 7,289 | |
Health & Safety | 95,522 | 18,114 | |
Revenue from customer contracts | 258,170 | 172,625 | |
In the first nine months of the year, GVS achieved consolidated revenues of Euro 258 million, up 49.6% from Euro 172.6 million in the same period of 2019. This result is mainly due to the growth of the Health & Safety division and the Healthcare & Life Sciences division, in both cases driven by the new needs arising from the spread of the COVID-19 pandemic. The drop in revenues from customer contracts, compared to the same period of the previous year, recorded by the Energy & Mobility division (-30%) also due to the exceptional nature of the period, was therefore more than offset by the increase in sales linked to the other sectors in which the Group operates.
Financial statements for the period closing at 30 September 2020 are shown below in comparison with those of the same period of the previous year, reclassified on the basis of current practice in financial analysis.
6
Analysis of reclassified financial position
Period ending on 30 September | ||||||||
of which | 2020 from | of which | 2019 from | |||||
non- | ordinary | non- | ordinary | |||||
(in thousands of Euro) | 2020 | recurring | operations | % | 2019 | recurring | operations | % |
Revenues from sales and services | 258,170 | 258,170 | 100.0% | 172,625 | 172,625 | 100.0% | ||
Other revenues and proceeds | 1,150 | 1,150 | 0.4% | 2,058 | 254 | 1,804 | 1.0% | |
Total revenues | 259,320 | 259,320 | 100.4% | 174,683 | 254 | 174,429 | 101.0% | |
Cost of raw materials purchases and variations in inventories | (61,433) | (61,433) | -23.8% | (52,013) | (52,013) | -30.1% | ||
Services | (25,807) | (4,544) | (21,263) | -8.2% | (17,417) | (235) | (17,182) | -10.0% |
Various operating costs | (2,161) | (2,161) | -0.8% | (2,811) | (144) | (2,667) | -1.5% | |
Added value | 169,919 | (4,544) | 174,463 | 67.6% | 102,443 | (125) | 102,568 | 59.4% |
Cost of labour | (71,489) | (1,080) | (70,409) | -27.3% | (55,792) | (147) | (55,645) | -32.2% |
EBITDA | 98,430 | (5,624) | 104,054 | 40.3% | 46,651 | (272) | 46,923 | 27.2% |
Amortisation and depreciation | (13,958) | (2,920) | (11,038) | -4.3% | (11,985) | (2,924) | (9,061) | -5.2% |
Provisions and writedowns | (181) | (181) | -0.1% | (207) | (207) | -0.1% | ||
EBIT | 84,291 | (8,544) | 92,835 | 36.0% | 34,459 | (3,196) | 37,655 | 21.8% |
Financial proceeds and charges | (9,195) | (9,195) | -3.6% | 1,238 | 1,238 | 0.7% | ||
Pre-tax result | 75,096 | (8,544) | 83,640 | 32.4% | 35,697 | (3,196) | 38,893 | 22.5% |
Income tax | (17,868) | 1,840 | (19,708) | -7.6% | (9,115) | 355 | (9,470) | -5.5% |
Group's and minority shareholders' net profit or lo ss | 57,228 | (6,704) | 63,932 | 24.8% | 26,582 | (2,841) | 29,423 | 17.0% |
The consolidated economic results of operations of the period closing at 30 September 2020 were as follows: total revenues from ordinary operations amounted to Euro 259.3 million (Euro 174.4 million in 2019); EBITDA from ordinary operations amounted to Euro 104.1 million (Euro 46.9 million in 2019); EBIT from ordinary operations came to Euro 92.8 million (Euro 37.7 million in 2019).
The trend in revenues from contracts with customers (+49.6% over 2019) is the result of sales trends in individual customer categories, as stated in the analysis above.
The percentage incidence of the first margin (total revenues, less purchase costs of goods plus change in inventories) on revenues from sales and services improved by 6.3 percentage points compared to last year. Such an increase is essentially due to procurement strategies implemented in the last three years. Other revenues and proceeds primarily represent contributions for operating expenses, recovery and chargeback of costs, insurance refunds and capital gains on sales. The balance of the item decreased by Euro 654 thousand, compared to the same period of the previous year, mainly due to less capital gains on sales of fixed assets and lower insurance reimbursements received during the period.
The "Added value" margin as a percentage of revenue s from sales and services improved in 2020 (+8.2 percentage points), compared to the same period of last year. This thanks to the cost containment policies implemented in the last three years combined with the rapid implementation of 41 new production lines in the various GVS Group plants, which allowed for a big increase in the level of operating leverage. As mentioned above, the reduction in variable costs was significant and service costs also grew less than proportionally with respect to sales, whose percentage of revenues from sales and services dropped from 10% in the period ended at 30 September 2019, to 8.2% in the same period of 2020.
The increase in absolute value of personnel costs in the period ended 30 June 2020 compared to the same period of the previous year is due to the strengthening of the Group's structure, also through fixed- term and temporary employment contracts to meet the growth in sales. The percentage impact of personnel costs on revenues from sales and services dropped over the previous year, however, from 32.2% in 2019 to 27.3% in 2020.
The increase in absolute value of the item amortisation, depreciation and write-downs for the period ended 30 September 2020 compared with the same period of the previous financial year is mainly due
7
to the acceleration of the investment plans implemented by the Group in the first months of 2020 to meet the increase in production capacity which was necessary.
Net financial charges (net of net exchange losses of €6,295 thousand recorded in the period ended 30 September 2020 and net profits on exchanges of €4,8 64 thousand recorded in 2019) decreased in the period. In fact, they went from €3,626 thousand in 2019 to €2,899 thousand in 2020, mainly due to the reduction in interest on loans, due to an improvement in the ratio between net financial indebtedness and EBITDA of the Group, as well as to the reduction of the residual debt related to the above- mentioned financial payables.
The result of recurrent activities reached Euro 63.9 million in 2020, Euro 34.5 million higher than the 2019 figure of Euro 29.5 million, due to the effect of the factors described above.
Non-recurrent proceeds and charges in the period ending on 30 September 2020 represent: (i) amortisation of intangible assets recorded following the purchase price allocation of the Kuss group (Euro 2,920 thousand), (ii) consultancy costs and one-off bonuses paid to personnel in relation to the IPO procedure concluded on 19 June 2020 (Euro 5,081 thousand), (iii) consultancy costs for purchase of the shareholding in Puerto Rico (Euro 259 thousand) and (iv) personnel reorganisation costs (Euro 284 thousand), net of the related tax effect.
Non-recurrent proceeds and charges in the period ending on 30 September 2019 represent: (i) amortisation of intangible assets entered following purchase price allocation of the Kuss Group (Euro 2,924 thousand), (ii) capital gains resulting from disposal of the real estate assets mentioned above (Euro 254 thousand), (iii) start-up costs incurred for the company established in Mexico (Euro 235 thousand), (iv) tax credits on indirect taxes of the company IOP (China) Filter Co. Ltd., written down following winding-up of the company (Euro 144 thousand), and (v) personnel reorganisation costs (Euro 147 thousand), net of the effect of taxation.
Analysis of reclassified equity position
At 30 September | At 31 December | |
(in thousands of Euro) | 2020 | 2019 |
Net intangible assets | 94,486 | 99,846 |
Net usage rights | 8,757 | 10,320 |
Net tangible assets | 67,295 | 46,614 |
Financial fixed assets | 900 | 377 |
Other fixed assets | 2,869 | 1,616 |
Fixed capital (A) | 174,306 | 158,773 |
Net trade receivables | 66,120 | 35,158 |
Inventories | 46,017 | 31,491 |
Payables to suppliers | (31,940) | (13,188) |
Net commercial working capital (B) | 80,197 | 53,461 |
Other current assets | 11,373 | 7,214 |
Other current liabilities | (34,224) | (17,063) |
Total current assets/liabilities (C) | (22,851) | (9,849) |
Net working capital (D)= (B) + (C) | 57,346 | 43,612 |
Other non-current liabilities (E) | (2,194) | (819) |
Employee termination indemnity and end of service indemnity (F) | (4,271) | (4,193) |
Net invested capital (H) = (A+D+E+F) | 225,187 | 197,373 |
Shareholders' equity | (223,992) | (94,240) |
Consolidated shareholders' equity (I) | (223,992) | (94,240) |
(Short-term financial indebtedness)/Liquidity | 86,013 | 22,355 |
(Net medium/long term financial indebtedness) | (87,209) | (125,488) |
Net financial indebtedness (L) | (1,196) | (103,133) |
8
Own funds and net financial indebtedness (M) = (I+L) | (225,187) | (197,373) |
Fixed capital as of 30 September 2020 showed an increase of Euro 15,534 thousand, as the reduction in net intangible assets and usage rights totalling Euro 6,923 thousand, has been offset by a net increase in tangible assets and other fixed assets of Euro 22,457 thousand.
The balance of trade net working capital at 30 September 2020 showed an increase of Euro 26,735 thousand, compared to 31 December 2019, with an increase in inventories and net trade receivables for a total amount of Euro 45,488 thousand against an increase in trade payables of Euro 18,753 thousand.
The increase in other current assets at 30 September 2020, equal to Euro 4,159 thousand, was mainly due to the increase in advances to suppliers and receivables for indirect taxes.
The increase in other current liabilities at 30 September 2020 compared to 31 December 2019, equal to Euro 17,162 thousand, was mainly due to advances paid by customers for Euro 2,971 thousand, the increase in payables for current taxes for Euro 12,145 thousand and the increase in payables to the personnel for Euro 2,852 thousand only partially offset by the decrease in payables for dividends, equal to Euro 1,681 thousand, paid after the end of the previous financial year.
Shareholders' equity at 30 September 2020 increased mainly due to the result for the period and the effects of the IPO process, which led to an increase in share capital and the share premium reserve of Euro 79,559 thousand.
The reader is referred to the next section for information on changes in net financial indebtedness.
Analysis of net financial indebtedness and net financial position
Trends in net financial indebtedness and net financial position are analysed below.
(in thousands of Euro) | At 30 September 2020 | At 31 December 2019 | |
Cash | 32 | 32 | |
Cash on hand | 112,157 | 58,510 | |
Term deposits | 360 | - | |
Shares held for trading | 3,650 | 3,399 | |
(A) | Liquidity | 116,199 | 61,941 |
Financial receivables due to leasing | 172 | 177 | |
(B) | Current financial receivables | 172 | 177 |
(C) | Current bank debts | (3,000) | |
(D) | Current portion of non-current indebtedness | (26,347) | (33,506) |
Financial payables to other companies in the GVS Group due to leasing | (965) | (585) | |
Financial payables for leasing | (2,479) | (2,509) | |
Other financial payables | (568) | (163) | |
(E) | Other current financial payables | (4,012) | (3,257) |
(F) | Current financial indebtedness (C)+(D)+(E) | (30,359) | (39,763) |
(G) | Net current financial indebtedness (A)+(B)+(F) | 86,013 | 22,355 |
Non-current bank debts | (44,496) | (67,999) | |
Non-current bonded loans | (36,812) | (49,574) | |
Financial payables to other companies in the GVS Group due to leasing | (2,240) | (1,886) | |
Non-current financial payables for leasing | (3,596) | (5,965) | |
Other financial payables | (65) | (65) | |
(H) | Non-current financial indebtedness | (87,209) | (125,488) |
(I) | Net financial indebtedness (G)+(H) | (1,196) | (103,134) |
Derivatives | |||
Financial payables for leasing (net) | 9,107 | 10,767 | |
(L) | Total net financial position | 7,911 | (92,366) |
9
The change in net financial indebtedness at 30 September 2020 as compared to 31 December 2019, totalling Euro 101,938 thousand, is primarily due to the combined effect of: (i) an increase in liquidity and current financial receivables totalling Euro 54,254 thousand, due to liquidity obtained from the IPO procedure and liquidity generated by operations, and (ii) a Euro 47,685 thousand reduction in current and non-current financial indebtedness, primarily due to repayment of long-term financial payables.
The Group's net financial position (excluding net current and non-current leasing liabilities, measured in accordance with the provisions of IFRS 16 and equal to a total of Euro 9,107 thousand at 30 September 2020 and Euro 10,767 thousand at 31 December 2019 respectively), amounted to positive Euro 7,911 thousand and negative Euro 92,366 thousand as of these dates. Note that a number of financial agreements require the GVS Group to meet certain financial parameters, which had been met as of 30 June 2020.
Cash flow statement
The cash flow statement appears below.
Period ending on 30 September | ||
(in thousands of Euro) | 2020 | 2019 |
Pre-tax result | 75,096 | 35,697 |
Amortisation, depreciation and writedowns | 13,958 | 11,985 |
Capital losses / (capital gains) from sale of assets | (10) | (214) |
Financial charges / (proceeds) | 9,195 | (1,238) |
Other non-monetary variations | 1,148 | 908 |
Cash flow generated / (absorbed) by operations before variations in net working capital | 99,387 | 47,138 |
Variation in inventories | (16,590) | (1,597) |
Variation in trade receivables | (27,352) | (1,084) |
Variation in trade payables | 25,963 | (2,676) |
Variation in other assets and liabilities | (2,770) | (2,063) |
Use of provisions for risks and charges and for employee benefits | (644) | (635) |
Taxes paid | (6,630) | (5,956) |
Net cash flow generated / (absorbed) by operations | 71,364 | 33,128 |
Investments in tangible assets | (22,176) | (7,689) |
Investments in intangible assets | (2,285) | (2,115) |
Disposal of tangible assets | 196 | 2,847 |
Investment in financial assets | (3,061) | (1,965) |
Disinvestment in financial assets | - | 1,700 |
Payment for purchase of business unit net of cash on hand acquired | (10,532) | - |
Net cash flow generated / (absorbed) by investment | (37,858) | (7,222) |
Opening of long-term financial payables | 503 | 6,500 |
Repayment of long-term financial payables | (41,955) | (22,982) |
Variations in current financial payables | (3,000) | - |
Repayment of leasing liabilities | (2,165) | (1,671) |
Financial charges paid | (4,018) | (4,184) |
Financial proceeds collected | 94 | 78 |
Net fee for IPO | 74,508 | - |
Dividends paid | (1,681) | (7,814) |
Net cash flow generated/(absorbed) by financial assets | 22,286 | (30,073) |
Total variation in cash on hand | 55,792 | (4,168) |
10
Cash on hand at the start of the year | 58,542 | 45,551 |
Total variation in cash on hand | 55,792 | (4,168) |
Conversion differences on cash on hand | (2,145) | 1,074 |
Cash on hand at the end of the year | 112,189 | 42,457 |
During the period ending on 30 September 2020, operations generated Euro 52,248 thousand more liquidity than in the same period of the previous year, primarily as a result of increased EBITDA; to the contrary, cash flows generated by working capital were Euro 14,012 thousand lower.
On the other hand, in 2020, net investment activity (ordinary and extraordinary acquisition operations) absorbed an overall increase in liquidity of €30,63 6 thousand compared to the same period in 2019, determining a cash flow generation before cash flows generated/absorbed by financial assets amounting to €33,506 thousand, €7,600 thousand higher than th e period ended 30 September 2019.
The cash flow generated by financial assets mainly increased as a result of the net increase in share capital against payment, determining an overall net cash flow from operating and investing activities, mentioned above, a net increase in cash on hand of €55,792 thousand, €59,960 thousand higher than the same period ended 30 September 2019.
Indicators
The Group's principal economic and financial indicators and other indicators at 30 September 2019 and 30 September 2020 are listed below.
Period ending on 30 September | ||
(numerical data in thousands of Euros) | 2020 | 2019 |
ROE (net profit/total net shareholders' equity) | 26% | 30% |
ROI (EBIT from ordinary operations/net invested capital) | 41% | 18% |
ROS (EBIT from ordinary operations/total revenues) | 36% | 22% |
EBITDA | 98,430 | 46,651 |
EBITDA from ordinary operations | 104,054 | 46,923 |
Net interest payable (excluding profits/losses on exchanges, Interest on actualisation of funds | ||
and proceeds due to sale of derivatives) | (2,899) | (3,626) |
Net Financial Debt | (1,196) | (118,878) |
Net financial position | 7,911 | (112,041) |
Total intangible fixed assets/Total fixed assets | 54% | 64% |
Total intangible fixed assets/Total assets | 23% | 35% |
Acid test (short-termassets/short-term liabilities) | 1.2 | 1.4 |
Net interest payable/net financial indebtedness | 242% | 3% |
Indebtedness ratio (net financial indebtedness/shareholders' equity) | 0.01 | 1.34 |
Net financial position/shareholders' equity | (0.04) | 1.26 |
EBITDA/Interest | 33.95 | 12.86 |
EBITDA from ordinary operations/Interest | 35.89 | 12.94 |
Net financial position/EBITDA | (0.08) | 2.40 |
Net financial position/EBITDA from ordinary operations | (0.08) | 2.39 |
Net financial debt / EBITDA | 0.01 | 2.55 |
Net financial indebtedness/EBITDA from ordinary operations | 0.01 | 2.53 |
11
Investments.
The Group's investment policy aims to achieve diversification in terms of product range and creation of new technological solutions for integration into the range of products it offers for sale. The development of new products is important for the Group, in order to continuously increase the satisfaction of its customers. Moreover, in the period under examination here, the Group has invested in improvement of the efficiency of production through reinforcement and boosting of automation processes and adaptation of its productive capacity to ensure immediate flexibility in response to a possible increase in activity and adaptability to emerging trends.
Investments for the first nine months were mainly attributable to the expansion of production capacity to meet the increase in sales orders of products of the Healthcare & Life Sciences division and the Health & Safety division.
With particular reference to the period ended 30 September 2020, significant investments were made to expand the production capacity of the production site in Mexico.
Research and development.
With research and development centres all over the world, GVS offers an extremely efficient service tailored to respond to its customers' requests: from product conception and design to validation and mass production.
The Group's R&D work aims to introduce new products and implement new production processes. These activities are divided into a number of different phases, from conception and start of the process of designing and new product process to large-scale industrial production. The main indicators for the period under review compared with the same period of the previous year are shown below.
Period ending 30 September | ||
(in thousands of Euro) | 2020 | 2019 |
Research and development costs | 14,124 | 13,139 |
Research and development costs/revenues from contracts with customers | 5.5% | 7.6% |
Significant events occurring during the period.
On 19 June 2020, the Company completed the listing process on the MTA market of the Italian Stock Exchange. Goldman Sachs International and Mediobanca - Banca di Credito Finanziario S.p.A. acted as joint global coordinators and joint bookrunners, Mediobanca - Banca di Credito Finanziario acted as Sponsor.
The period closing at 30 September 2020 was highly influenced by the COVID-19 pandemic (commonly known as Coronavirus). During this period, the Group implemented organisational measures and procedures to ensure the continuation of production and management activities, so as to guarantee respect for commitments made to customers, while fully respecting the health of its employees and collaborators. In fact, if on the one hand the pandemic has led to a contraction in demand for products in the Energy & Mobility division, on the other it has brought a significant increase in sales volumes of products in the Healthcare & Life Sciences division and the Health & Safety division. The Group has been strongly committed to guaranteeing the production levels of products in demand as a result of the pandemic, also through investments made from March 2020.
In the previous year, the subsidiary GVS Technology (Suzhou) Co. Ltd., had stipulated an investment memorandum with the Chinese government under which the Chinese subsidiary is required to move its production facility in Suzhou. Following the relocation process, GVS Technology (Suzhou) Co. Ltd. will benefit not only from payment for the sale of the production facility but from: (i) refund of a portion of the taxes paid in each of the years in the 2020-2022three-year period; (ii) a contribution proportionate to investment in plant and machinery; (iii) an additional contribution for development of the new production site, and (iv) a payment as reimbursement for machinery which cannot be removed from the
12
production site relocated. Also note that following the stipulation of the investment memorandum, GVS Technology (Suzhou) Co. Ltd. has agreed to: (i) increase its share capital up to the amount of USD 12 million, possibly through use of reserves, and (ii) to increase investment in ordinary operations. During the first nine months of the year, in accordance with the above GVS Technology (Suzhou) Co. Ltd. increased its share capital through the use of reserves by approximately RMB 19 million and at the same time the Chinese government paid an advance for the future sale of the property for an amount of approximately RMB 9.8 million. Note that the methods and timing of the investment and move of the production site will be agreed on by the parties at a subsequent time with the goal of preventing interruptions in the production and sale of products.
During the month of January 2020, the GVS Group, through its subsidiary GVS Filter Technology de Mexico S. de. R.L. de C.V., completed the acquisition of a business unit related to products of the Life Sciences business, previously controlled by Graphic Controls Acquisition Corp. In addition, at the end of the first half, it signed a contract for purchase of a stake in Haemonetics Puerto Rico LLC, a company operating in the Healthcare business.
In July 2020, GVS paid off loans to Unicredit, Banco Popolare di Milano and Banca Nazionale del Lavoro early for a total amount of Euro 12,525 thousand against available liquidity.
In August 2020, following the sales made by the Group in the first six months after the acquisition, relating to the products of the business unit acquired from Graphic Controls Acquisition Corp, GVS released and made the amount of USD 1,000 thousand available from the escrow account in favour of the seller. The remainder, equal to USD 1,000 thousand will be issued, whether or not in favour of the seller, on the basis of the revenues that will be realised in the second half of the year following the date of acquisition.
On 9 September 2020, the Board of Directors approved, subject to the opinion of the Appointments and Remuneration Committee, the assignment of rights on shares to the beneficiaries of the 2020-2022 Performance Shares Plan, for execution of the resolution of the Shareholders' Meeting of 13 March 2020 and in line with what was announced at the time of listing.
Events subsequent to the close of the period
The partial spin-off through the assignment of part of the share capital of GVS Microfiltrazione S.r.l. to the newly incorporated company GVS Patrimonio Immobiliare S.r.l. (see note "Events of significance following the close of the financial period" in the Consolidated Financial Statements for the year ended 31 December 2019), the draft of which was approved on 20 January 2020, due to administrative slowdowns, is not yet legally effective.
In October 2020, GVS S.p.A. paid off a Club Deal loan to Unicredit, Mediobanca and Banca Nazionale del Lavoro early for a total amount of Euro 58,500 thousand against available liquidity. The repayment will allow the GVS Group, to optimise the Group's financial structure by reducing the average annual cost of medium/long-term debt, without any significant impact on the net financial position or the sources of support of the Company's activities.
Business outlook
The GVS Group will continue to respond quickly to the demands of the market and its customers in the last quarter as well. Depending on the amount of revenues from customer contracts and the order backlog achieved to date, the GVS group expects to achieve revenues for the year in the order of €350 million, up by more than 50% compared to the revenues recorded in the year ended 31 December 2019, due to the remarkable performance related to sales of respiratory filters and personal protective equipment resulting from the need to respond to the emergency generated by COVID-19. The above forecasts are linked to the orders already in the portfolio for the three business divisions of the GVS Group and the expected growth in revenues is entirely driven by the Healthcare & Life Sciences and Health & Safety divisions, while the Energy & Mobility division will continue to decline, although
13
with a less negative trend than forecast at the beginning of the year. In terms of profitability, the last quarter of the year should confirm the progressive results achieved at the end of September.
Zola Predosa, 05 November 2020
For the Board of Directors
Massimo Scagliarini
Chief Executive Officer
14
FINANCIAL STATEMENTS AT 30 SEPTEMBER 2020
Consolidated statement of assets and liabilities*
(in thousands of Euro) | At 30 September 2020 | At 31 December 2019 |
ASSETS | ||
Non-current assets | ||
Intangible assets | 94,486 | 99,846 |
Assets represented by usage rights | 8,757 | 10,320 |
Tangible assets | 67,295 | 46,614 |
Advance tax assets | 2,840 | 1,451 |
Non-current financial assets | 929 | 542 |
Total non-current assets | 174,307 | 158,773 |
Current assets | ||
Inventories | 46,017 | 31,491 |
Trade receivables | 66,120 | 35,158 |
Assets from contracts with customers | 1,631 | 591 |
Current tax receivables | 256 | 193 |
Other receivables and current assets | 9,486 | 6,430 |
Current financial assets | 4,182 | 3,576 |
Cash on hand | 112,189 | 58,542 |
Total current assets | 239,881 | 135,981 |
TOTAL ASSETS | 414,188 | 294,754 |
SHAREHOLDERS' EQUITY AND LIABILITIES | ||
Share capital | 1,750 | 1,650 |
Reserves | 165,003 | 59,489 |
Net income | 57,216 | 33,083 |
Group net shareholders' equity | 223,970 | 94,222 |
Minority interests | 22 | 18 |
Total shareholders' equity | 223,992 | 94,240 |
Non-current liabilities | ||
Non-current financial liabilities | 81,373 | 117,638 |
Non-current leasing liabilities | 5,836 | 7,850 |
Deferred tax liabilities | 2,194 | 819 |
Provisions for employee benefits | 4,271 | 4,193 |
Total non-current liabilities | 93,674 | 130,500 |
Current liabilities | ||
Current financial liabilities | 26,915 | 36,669 |
Current leasing liabilities | 3,444 | 3,094 |
Trade payables | 31,940 | 13,188 |
Liabilities from contracts with customers | 4,673 | 1,702 |
Current tax payables | 14,205 | 2,060 |
Other current payables and liabilities | 15,345 | 13,301 |
Total current liabilities | 96,522 | 70,014 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 414,188 | 294,754 |
- Pursuant to the CONSOB Resolution No. 15519 of 27 July 2016, the effects of transactions with related parties on consolidated statement of assets and liabilities are highlighted in the attached tables.
15
Consolidated income statement*
The 9-month period closed on 30th | ||
(in thousands of Euro) | September | |
2020 | 2019 | |
Revenue from customer contracts | 258,170 | 172,625 |
Other revenues and proceeds | 1,150 | 2,058 |
Total revenues | 259,320 | 174,683 |
Purchases and consumption of raw materials, semi-products and finished products | (61,433) | (52,013) |
Personnel costs | (71,489) | (55,792) |
Service costs | (25,807) | (17,417) |
Other operating costs | (2,161) | (2,811) |
EBITDA | 98,430 | 46,651 |
Net writedowns of financial assets | (181) | (207) |
Amortisation, depreciation and writedowns | (13,958) | (11,985) |
EBIT | 84,291 | 34,459 |
Financial proceeds | 94 | 4,942 |
Financial charges | (9,289) | (3,704) |
Pre-tax result | 75,096 | 35,697 |
Income tax | (17,868) | (9,115) |
Net income | 57,228 | 26,582 |
Group's share | 57,216 | 26,579 |
Minority share | 12 | 3 |
Basic net profit per share | 0.46 | 0.21 |
Diluted net profit per share | 0.45 | 0.21 |
- Pursuant to the CONSOB Resolution no. 15519 of 27 July 2016, the effects of transactions with related parties on consolidated income statement are highlighted in the attached tables.
16
Comprehensive consolidated income statement
The 9-month period closed on 30th | ||
(in thousands of Euro) | September | |
2020 | 2019 | |
Net income | 57,228 | 26,582 |
Other components of the comprehensive income statement which will | ||
be reclassified in the income statement in subsequent years | ||
Difference due to conversion of financial statements in foreign currency | (6,936) | 1,000 |
(6,936) | 1,000 | |
Other components of the comprehensive income statement which will | ||
not be reclassified in the income statement in subsequent years | ||
Actuarial profit (loss) due to employee defined benefit plans | - | |
Effect of taxation | - | |
- | - | |
Total other components in the comprehensive income statement | (6,936) | 1,000 |
Comprehensive net profit | 50,292 | 27,582 |
Group's share | 50,288 | 27,584 |
Minority share | 4 | (2) |
17
Prospectus of changes in consolidated shareholders' equity
Reserves | ||||||||||||
Share | Group net | Minority | Total | |||||||||
(in thousands of Euro) | Profit (loss) | Net income | shareholders' | shareholders' | ||||||||
capital | Extraordinary | Negative reserve | Actuarial profits | interests | ||||||||
Share premium reserve | Legal reserve | Translation reserve | carried over and | equity | equity | |||||||
reserve | for treasury shares | and losses reserve | ||||||||||
other reserves | ||||||||||||
At 31 December 2018 | 1,650 | 13,247 | 329 | 25,831 | (3,267) | (10,981) | 52 | 21,092 | 23,072 | 71,025 | 16 | 71,041 |
Net income | - | - | - | - | - | - | - | - | 26,579 | 26,579 | 3 | 26,582 |
Total other components in the comprehensive income statement | - | - | - | - | 1,005 | - | - | - | - | 1,005 | (5) | 1,000 |
Comprehensive net profit | - | - | - | - | 1,005 | - | - | - | 26,579 | 27,584 | (2) | 27,582 |
Allocation of net profit from previous year | - | - | - | 9,924 | - | - | - | 13,148 | (23,072) | - | - | - |
Dividends distributed | - | - | - | (10,010) | - | - | - | - | - | (10,010) | - | (10,010) |
At 30 September 2019 | 1,650 | 13,247 | 329 | 25,745 | (2,262) | (10,981) | 52 | 34,240 | 26,579 | 88,599 | 14 | 88,613 |
Reserves | ||||||||||||
Share | Group net | Minority | Total | |||||||||
(in thousands of Euro) | Profit (loss) | Net income | shareholders' | shareholders' | ||||||||
capital | Extraordinary | Negative reserve | Actuarial profits | interests | ||||||||
Share premium reserve | Legal reserve | Translation reserve | carried over and | equity | equity | |||||||
reserve | for treasury shares | and losses reserve | ||||||||||
other reserves | ||||||||||||
At 31 December 2019 | 1,650 | 13,247 | 329 | 25,745 | (3,040) | (10,981) | (51) | 34,240 | 33,083 | 94,222 | 18 | 94,240 |
Net income | - | - | - | - | - | - | - | 57,216 | 57,216 | 12 | 57,228 | |
Total other components in the comprehensive income statement | - | - | - | - | (6,928) | - | - | - | - | (6,928) | (8) | (6,936) |
Comprehensive net profit | - | - | - | - | (6,928) | - | - | - | 57,216 | 50,288 | 4 | 50,292 |
Allocation of net profit from previous year | - | - | 15,114 | - | - | - | 17,969 | (33,083) | - | - | - | |
Cancellation of treasury shares | - | - | - | (10,981) | - | 10,981 | - | - | - | - | - | - |
Capital increase | 100 | 81,400 | - | - | - | - | - | - | - | 81,500 | - | 81,500 |
Accessory costs to the capital increase | - | (2,692) | - | - | - | - | - | - | - | (2,692) | - | (2,692) |
Taxes relating to capital increase costs | - | 751 | - | - | - | - | - | - | - | 751 | - | 751 |
Increase in performance shares reserve | - | - | - | - | - | - | - | 245 | - | 245 | - | 245 |
Profit sharing of GVS Mexico employees | - | - | - | - | - | - | - | (345) | - | (345) | - | (345) |
At 30 September 2020 | 1,750 | 92,706 | 329 | 29,878 | (9,968) | - | (51) | 52,109 | 57,216 | 223,969 | 22 | 223,991 |
18
Consolidated statement of cash flows*
(in thousands of Euro) | The 9-month period closed on 30th September | |
2020 | 2019 | |
Pre-tax result | 75,096 | 35,697 |
- Adjustment for: | ||
Amortisation, depreciation and writedowns | 13,958 | 11,985 |
Capital losses / (capital gains) from sale of assets | (10) | (214) |
Financial charges / (proceeds) | 9,195 | (1,238) |
Other non-monetary variations | 1,148 | 908 |
Cash flow generated / (absorbed) by operations before variations in net working | 99,387 | 47,138 |
capital | ||
Variation in inventories | (16,590) | (1,597) |
Variation in trade receivables | (27,352) | (1,084) |
Variation in trade payables | 25,963 | (2,676) |
Variation in other assets and liabilities | (2,770) | (2,063) |
Use of provisions for risks and charges and for employee benefits | (644) | (635) |
Taxes paid | (6,630) | (5,956) |
Net cash flow generated / (absorbed) by operations | 71,364 | 33,128 |
Investments in tangible assets | (22,176) | (7,689) |
Investments in intangible assets | (2,285) | (2,115) |
Disposal of tangible assets | 196 | 2,847 |
Investment in financial assets | (3,061) | (1,965) |
Disinvestment in financial assets | - | 1,700 |
Payment for purchase of business unit net of cash on hand acquired | (10,532) | - |
Net cash flow generated / (absorbed) by investment | (37,858) | (7,222) |
Opening of long-term financial payables | 503 | 6,500 |
Repayment of long-term financial payables | (41,955) | (22,982) |
Variations in current financial payables | (3,000) | - |
Repayment of leasing liabilities | (2,165) | (1,671) |
Financial charges paid | (4,018) | (4,184) |
Financial proceeds collected | 94 | 78 |
Net fee for IPO | 74,508 | |
Dividends paid | (1,681) | (7,814) |
Net cash flow generated/(absorbed) by financial assets | 22,286 | (30,073) |
Total variation in cash on hand | 55,792 | (4,168) |
- | ||
Cash on hand at the start of the year | 58,542 | 45,551 |
Total variation in cash on hand | 55,792 | (4,168) |
Conversion differences on cash on hand | (2,145) | 1,074 |
Cash on hand at the end of the year | 112,189 | 42,457 |
- Pursuant to the CONSOB Resolution no. 15519 of 27 July 2016, the effects of transactions with related parties on consolidated cash flows are highlighted in the attached tables.
19
EXPLANATORY NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS AT 30 SEPTEMBER 2020
1. General information
1.1 Foreword
GVS S.p.A. (hereinafter referred to as " GVS", the " Company" or the " Parent Company" and, with its subsidiaries, as the " GVS Group" or simply the " Group") is a company established and domiciled in Italy, with registered offices in Zola Predosa (BO), Via Roma 50, organised according to the law of the Republic of Italy.
GVS is owned by the company GVS Group S.p.A. (hereinafter the " GVS Group"), which directly holds 60% of the share capital. There is no other entity exercising direction and coordination of the Company.
The GVS Group is a leading supplier of advanced filtering solutions for highly critical applications and offers advanced filtering solutions for a multitude of applications in a number of highly regulated sectors, organised into the following business divisions: Healthcare & Life Sciences, Energy & Mobility and Health & Safety.
2. Structure and content of the consolidated financial statements
2.1 Basic method of preparation
The Interim Report on Operations at 30 September 2020 was prepared in accordance with the valuation and measurement criteria established by the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) and adopted by the European Commission in accordance with the procedure set out in Art. 6 of Regulation (EC) No. 1606/2002 of the European Parliament and of the Council of 19 July 2002, while reference was made to Art. 154-ter of Legislative Decree No. 58 of February 24, 1998 for the purpose of this report.
The accounting standards adopted for this interim report are the same as those used to prepare the annual consolidated financial statements closing at 31 December 2019, to which reference should be made for further details, with the exception of the following:
- accounting standards, or amendments to existing accounting standards, effective from 1 January 2020 (see note 3 for more details), and
- income taxes, recognised on the basis of the best estimate of the weighted average tax rate expected for the entire year, in line with the provisions of IAS 34.
For comparison purposes, the consolidated financial statements at 30 September 2020 show, for the income statement the figures for nine months of 2019, while for the balance sheet the balances for the year ended 31 December 2019.
The Group chose to represent its statement of profit and loss according to the nature of the expense, while the assets and liabilities in the statement of financial position are divided into current and non- current. The statement of cash flows is prepared by the indirect method. The schemes employed are those that best represent the Group's economic and financial standing.
The currency in which the Company operates and uses for presentations is the Euro.
The statements and tables contained in this periodic report are shown in thousands of Euros.
20
The Interim Report on Operations is not subject to audit.
With reference to the prospect of business continuity, it should be noted that, in view of the spread of COVID-19 globally during 2020, the Group's economic and financial performance in the period ended 30 September 2020 was higher than previously expected. In particular, the trends recorded in the first nine months of 2020 lead us to believe that the Group's performance will be in line with the forecasts made in the business plan, if not better, although with a different distribution of revenues and investments among the divisions in which the Group operates. It should also be noted that cash and cash equivalents at 30 September 2020, amounting to Euro 112.2 million, the credit lines currently available and the cash flows that will be generated by operations, are considered more than sufficient to meet the Group's obligations and finance its operations.
With regard to performance in the first nine months of 2020, please read the Directors' Report on Operations.
2.2 Consolidation criteria and methods
The interim report on operations includes the statement of financial position and the statement of profit and loss of the Company and its subsidiaries, prepared on the basis of their accounting situations and, where applicable, opportunely corrected to ensure that they conform to EU-IFRS.
The table below lists information on the company name, registered offices, currency of operation, share capital and portion thereof owned directly by the Group for all GVS's subsidiaries.
Percentage of control | ||||||
Share | ||||||
Name | Registered offices | Currenc | capital at | Direct owner | At 31 | |
y | 30 June | At 30 June | ||||
December | ||||||
2020 | 2020 | |||||
2019 | ||||||
GVS Sud Srl | Italy - Zola Predosa (BO) | EUR | 10,000 | GVS SpA | 100.00% | 100.00% |
YUYao Yibo Medical Device Co. Ltd | China - Yuyao | CNY | 5,420,000 | GVS Technology (Suzhou) Co. Ltd. | 100.00% | 100.00% |
GVS Technology (Suzhou) Co. Ltd. | China - Suzhou (RPC) | CNY | 25,297,047 | GVS SpA | 100.00% | 100.00% |
Suzhou GVS Trading Co. Ltd. | China - Ningbo | CNY | 250,000 | GVS Technology (Suzhou) Co. Ltd. | 100.00% | 100.00% |
GVS Fortune Holding Ltd | Hong Kong (RPC) | HKD | 1 | GVS SpA | 100.00% | 100.00% |
GVS North America Inc | USA - Sanford (MA) | USD | n.a. | GVS North America Holdings Inc | 100.00% | 100.00% |
GVS Filtration Inc | USA - Findlay (OH) | USD | 10 | GVS North America Holdings Inc | 100.00% | 100.00% |
GVS North America Holdings Inc | USA - Sanford (MA) | USD | 0.10 | GVS SpA | 100.00% | 100.00% |
Fenchurch Environmental Group Ltd | United Kingdom - Morecambe | GBP | 1,469 | GVS SpA | 100.00% | 100.00% |
GVS Filter Technology UK Ltd | United Kingdom - Morecambe | GBP | 27,000 | Fenchurch Environmental Group Ltd | 100.00% | 100.00% |
GVS do Brasil Ltda | Brazil - Municipio de Monte Mor, Campinas | BRL | 20,755,226 | GVS SpA | 99.95% | 99.95% |
GVS Argentina Sa | Argentina - Buenos Aires | ARS | 1,510,212 | GVS SpA | 94.12% | 94.12% |
GVS Filter Technology de Mexico | Mexico - Nuevo Leon | MXN | 50,000 | GVS SpA | 99.90% | 99.90% |
GVS Korea Ltd | Korea - Seoul | KRW | 100,000,000 | GVS SpA | 100.00% | 100.00% |
GVS Microfiltrazione Srl | Romania - Ciorani | RON | 1,600 | GVS SpA | 100.00% | 100.00% |
GVS Japan KK | Japan - Tokyo | JPY | 1,000,000 | GVS SpA | 100.00% | 100.00% |
GVS Russia LLC | Russia - Moscow | RUB | 10,000 | GVS SpA | 100.00% | 100.00% |
GVS Filtre Teknolojileri | Turkey - Istanbul | TRY | 100,000 | GVS SpA | 100.00% | 100.00% |
GVS Puerto Rico LLC | Puerto Rico - Fajardo | USD | n.a. | GVS SpA | 100.00% | 0.00% |
In the period ended 30 September 2020, the scope of consolidation changed from the previous year, following the purchase of Haemonetics (now GVS Puerto Rico LLC). The acquisition took place on 29 June 2020 against which the economic effects from the date of acquisition have been recorded in the Interim Report on Operations, resulting in a decrease in the consolidated profit and loss and in the consolidated shareholders' equity for the period of €280 thousand and €670 thousand respectively.
21
It should also be noted that on 29 September 2020 the company GVS Filtration SDN. BHD. was created in Malaysia. As at 30 September, this company was not operational and the share capital had not yet been paid in.
The table below lists the exchange rates used for conversion of the financial statements of companies operating in a currency other than the Euro for the periods indicated:
Currency | At 30 September 2020 | At 31 December 2019 | Period ending on 30 September | |
2020 | 2019 | |||
Brazilian Real | 6.6308 | 4.5157 | 5.7100 | 4.3646 |
Argentine Peso | 89.1232 | 67.2749 | 76.0339 | 49.8762 |
Swiss Franc | 1.0804 | 1.0854 | 1.0680 | 1.1179 |
Chinese Renminbi | 7.9720 | 7.8205 | 7.8659 | 7.7135 |
American Dollar | 1.1708 | 1.1234 | 1.1250 | 1.1236 |
Hong Kong Dollar | 9.0742 | 8.7473 | 8.7273 | 8.8074 |
Japanese Yen | 123.7600 | 121.9400 | 120.9108 | 122.5696 |
Korean Won | 1,368.5100 | 1,296.2800 | 1,349.7389 | 1,306.3774 |
Swedish Crown | 10.5713 | 10.4468 | 10.5602 | 10.5679 |
Russian Ruble | 91.7763 | 69.9563 | 79.9599 | 73.0853 |
Turkish Lira | 9.0990 | 6.6843 | 7.5991 | 6.3390 |
Mexican Peso | 26.1848 | 21.2202 | 24.5232 | 21.6336 |
Romanian Ron | 4.8725 | 4.7830 | 4.8269 | 4.7382 |
British Pound | 0.9124 | 0.8508 | 0.8851 | 0.8835 |
Consolidation is carried out by using the line-by-line method, which consists of the inclusion of all assets and liabilities in their entirety. Subsidiaries are consolidated from the date on which control is effectively transferred to the Group, and cease to be consolidated on the date on which control is transferred outside the Group. The assets and liabilities, expenses and income of companies consolidated on a line-by-line basis are fully included in the consolidated financial statements. The book value of equity investments is eliminated against the corresponding portion of shareholders' equity of the investee companies by assigning to the individual assets and liabilities their current value at the date of acquisition of control (acquisition method as defined by IFRS 3 "Business Combinations"). Any residual difference, if positive, is recorded at the asset item "Goodwill"; if negative, on the income statement. Reciprocal payables and receivables, costs and revenues between consolidated companies and the effects of all significant transactions between them are eliminated. Minority interests in equity and results for the period are shown separately in the consolidated shareholders' equity and income statement: such an interest is determined on the basis of the percentage they hold in the fair values of assets and liabilities recognised at the original acquisition date and in the changes in equity after that date. Subsequently, profits and losses are attributed to minority shareholders according to the percentage held by them and losses are attributed to minority shareholders even if this implies that minority interests have a negative balance. Changes in the parent company's interest in a subsidiary that do not result in the loss of control are entered in the accounts as equity transactions. If the parent company loses control of a subsidiary, it eliminates the assets (including any goodwill) and liabilities of the subsidiary, eliminates the book values of any non-controlling interest in the former subsidiary, eliminates cumulative exchange differences recognised in equity, recognises the fair value of the consideration received, recognises the fair value of any retained interest in the former subsidiary, recognises any gain or loss in profit or loss, and finally reclassifies the parent company's share of the components previously recognised in comprehensive income to the income statement or loss or retained earnings, as appropriate.
22
3. Valuation criteria
The valuation criteria used for the preparation of the consolidated financial statements for the period ended 30 September 2020 do not differ from those used for the preparation of the consolidated financial statements for the year ended 31 December 2019, with the exception of the new accounting principles, amendments and interpretations applicable from 1st January 2020, which, however, have not had a significant impact on the Group's current financial position and results.
Accounting standards which are not yet applicable as they have not yet been approved by the European Union
As of the date of approval of this interim report on operations, the competent European Union bodies have not yet concluded the approval process required for adoption of the following accounting standards and amendments:
Accounting standard/amendment | Approved by the EU | Date of efficacy |
IFRS 17 Insurance Contracts | NO | 1 January 2021 (possible extension until 1 January |
2022) | ||
Amendments to IAS 1 Presentation of Financial | ||
Statements: Classification of Liabilities as Current or | NO | 1 January 2023 |
Non-current (issued on 23 January 2020) | ||
Future application of these accounting standards and amendments is not expected to have an impact on the Group's consolidated financial statement.
International accounting standards and/or endorsed interpretations in force since 1 January 2020
In accordance with IAS 8 "Accounting Policies, Chan ges in Accounting Estimates and Errors", the IFRS in force from 1 January 2020 are indicated below.
Accounting standard/amendment | Description |
Amendments to IAS 1 and IAS 8: | These changes not only clarify the concept of material but focus on a single |
consistent definition of material for all accounting standards and incorporate the | |
Definition of Material | guidelines included in IAS 1 regarding intangible information. There were no |
impacts on the Group's financial statements due tothe application of these changes. | |
Amendments to References to the | These changes focus on the updating of a number of definitions and references |
Conceptual Framework in IFRS | contained in various accounting standards, and their interpretation. There were no |
Standards | impacts on the Group's financial statements due tothe application of these changes. |
These changes focus on accounting representation of hedges, with the aim of | |
Amendments to IFRS 9, IAS 39, | clarifying the potential effects of uncertainty caused by " Interest Rate Benchmark |
Reform". These changes also ask companies to supply addit ional information of | |
IFRS 7 (Interest Rate Benchmark | |
use to investors regarding hedging relationships directly affected by this | |
Reform) | |
uncertainty. There were no impacts on the Group's financial statements due to the | |
application of these changes. | |
Amendment to IFRS 3 Business | These changes focus on the definition of business in such a way as to further clarify |
if the item purchased is a business or a group of assets. This amendment applies to | |
Combinations | the accounting for the Acquisition of the GCA Business Unit and the Purchase of |
the share in Haemonetics by the Group. |
4. Estimates and assumptions
The preparation of this Report requires the Directors to make estimates and assumptions that affect the values of costs, assets and liabilities on the financial statements. If in the future these estimates and
23
assumptions, which are based on management's best valuation, should differ from the actual circumstances, they will be modified appropriately in the period in which the circumstances change. It should also be noted that certain valuation processes, in particular the more complex ones such as the determination of any impairment of fixed assets, are generally carried out in full only at the time of preparation of the annual financial statements, when all the necessary information is available, except in cases where there are impairment indicators that require an immediate assessment of any loss in value.
5. Business combinations
Acquisition of the GCA Business Unit
On 30 October 2019, the GVS Group, through its subsidiary GVS Filter Technology de Mexico S. de. R.L. de C.V., signed a contract with Graphic Controls Acquisition Corp. concerning the Acquisition of the GCA Business Unit consisting of a complex of assets, including stock inventories representing filters and tangible assets representing plants and machinery, intangible assets and other assets as defined in the contract. As part of the above contract, GVS Filter Technology de Mexico also took over certain previously existing sales and supply contracts. The purchase was completed on 20 January 2020 (Closing Date).
The contract specified a provisional cost of USD 3,970 thousand, of which:
- USD 1,970 thousand paid by GVS Filter Technology de Mexico on the Closing Date, adjusted on the basis of any differences between the value of inventory in stock as of the Closing Date and its target value as defined in the contract (the " Price Adjustment"), which must be settled by the parties either (i) sixty days after the Closing Date, or (ii) ten days after the date on which the parties agree on the value of inventory as of the Closing Date, whichever comes later, and
- a variable component (potential consideration) based on sales to a number of customers in the twelve months subsequent to the Closing Date, for an amount between USD 200 thousand and USD 2,000 thousand, to be settled via an escrow account opened by GVS Filter Technology de Mexico on the Closing Date.
The fair value of the potential consideration, equal to Euro 2,000 thousand, was estimated on the basis of the present value of expected future cash flows. In view of the fact that this potential consideration will be determined on the basis of revenues recorded in the twelve months following the Closing Date, no adjustment has been made to the consideration for the transaction to take into account the effects of the time value of money.
It should be noted that on 20 May 2020, the parties determined the final value of the transferred inventory and consequently the Price Adjustment, against which GVS Filter Technology de Mexico collected USD 170 thousand.
Finally, it should be noted that during August 2020, following sales made by the Group in the first six months after the acquisition, GVS released the amount of USD 1,000 thousand from its escrow account in favour of the seller. The remainder equal to USD 1,000 thousand will be issued, whether or not in favour of the seller, on the basis of revenues recorded in the second half of the year following the Closing Date.
The table below reports the fair value of the assets and liabilities identifiable as of the date of the takeover.
24
(in thousands of Euro) | Provisional fair value as of the purchase date |
Tangible assets | 1,217 |
Inventories | 1,303 |
Total net assets acquired (A) | 2,520 |
Consideration (B) | 3,455 |
Goodwill (B) - (A) | 935 |
Goodwill has been provisionally recognised for an amount of Euro 935 thousand, as the valuation period as defined by IFRS 3 is in progress.
The contribution made by the acquired business to the Group's revenues from contracts with customers in the period ending on 30 September 2020 was Euro 1,265 thousand.
Acquisition of Haemonetics Puerto Rico LLC (now GVS Puerto Rico LLC)
On 2 June 2020, GVS entered into a contract with Haemonetics S.A. and Haemonetics Corporation for the purchase of the stake held by Haemonetics S.A. in Haemonetics Puerto Rico LLC (equal to all the shares). The transaction was completed on 29 June 2020 (Closing Date), against payment of approximately USD 15,500 thousand.
The purchase price is provisional and may be subject to certain adjustments (upwards or downwards) should the final value of the working capital deviate from the value previously indicated by the seller on the Closing Date.
The table below reports the fair value of the assets and liabilities identifiable as of the date of the takeover.
(in thousands of Euro) | Provisional fair value as of the |
purchase date | |
ASSETS | |
Non-current assets | |
Tangible assets | 7,388 |
Total non-current assets | 7,388 |
Current assets | |
Inventories | 2,965 |
Other receivables and current assets | 248 |
Cash on hand | 6,480 |
Total current assets | 9,693 |
Total assets | 17,081 |
Non-current liabilities | |
Deferred tax liabilities | 348 |
Total non-current liabilities | 348 |
Current liabilities | |
Trade payables | 852 |
Current tax payables | 1,442 |
Other current payables and liabilities | 882 |
Total current liabilities | 3,176 |
25
Total liabilities | 3,524 |
Total net assets acquired (A) | 13,557 |
Consideration (B) | 13,557 |
Goodwill (B) - (A) | - |
The fair value of the acquired assets and liabilities identifiable at the date of acquisition and goodwill (zero) have been recognised on a provisional basis, as the valuation period as defined by IFRS 3 is ongoing.
The contribution made by the acquired business to the Group's revenues from contracts with customers in the period ending on 30 September 2020 was Euro 5,617 thousand.
6. Explanatory Notes to the main consolidated income statement items
6.1 Revenue from customer contracts
The table below breaks down revenues from contracts with customers by division in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Healthcare Liquid | 56,991 | 51,408 | |
Healthcare Air & Gas | 42,589 | 20,175 | |
Laboratory | 15,818 | 15,058 | |
Healthcare & Lifesciences | 115,398 | 86,640 |
Powertrain & Drivetrain | 20,216 | 31,932 |
Safety & Electronics | 14,073 | 16,484 |
Sport & Utility | 12,962 | 19,455 |
Energy & Mobility | 47,250 | 67,871 |
Personal Safety | 90,864 | 10,825 |
Air Safety | 4,658 | 7,289 |
Health & Safety | 95,522 | 18,114 |
Revenue from customer contracts | 258,170 | 172,625 |
The increase in revenues in the period ended 30 September 2020 compared to the period of the previous year is mainly due to the increase in turnover achieved in the Health & Safety and Healthcare & Life Sciences divisions.
The table below breaks down revenues from contracts with customers by type of sale in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Business to business (BTB) | 134,786 | 142,112 | |
Business to consumer (BTC) | 123,384 | 30,513 | |
Revenue from customer contracts | 258,170 | 172,625 |
The table below breaks down revenues from contracts with customers by geographic area in the periods ending on 30 September 2019 and 2020.
26
(in thousands of Euro) | The 9-month period closed on 30th September | |
2019 | ||
2020 | ||
North America | 90,850 | 73,169 |
Europe | 114,156 | 49,609 |
Asia | 37,036 | 35,107 |
Other countries | 16,128 | 14,740 |
Revenue from customer contracts | 258,170 | 172,625 |
6.2 Other revenues and proceeds
The table below breaks down other revenues and proceeds for the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Contributions for operating expenses | 184 | 360 | |
Recovery and chargeback | 329 | 424 | |
Insurance refunds | - | 111 | |
Recovery of scrap | 174 | 129 | |
Capital gains on sales | 10 | 254 | |
Other | 453 | 780 | |
Other revenues and proceeds | 1,150 | 2,058 |
6.3 Purchases and consumption of raw materials, semi-products and finished products
The table below breaks down purchases and consumption of raw materials, semi-products and finished products in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th | ||
(in thousands of Euro) | September | |
2020 | 2019 | |
Purchases of raw materials | 72,514 | 54,420 |
Variation in inventories of products in progress, semi-products and finished | (4,108) | (303) |
products | ||
Variation in inventories of raw materials, subsidiary materials and goods | (6,973) | (2,104) |
Purchases and consumption of raw materials, semi-products and | 61,433 | 52,013 |
finished products | ||
6.4 Personnel costs
The table below breaks down personnel costs in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Salaries and wages | 55,724 | 43,185 | |
Social security contributions | 14,799 | 11,872 | |
Cost of termination indemnity | 681 | 661 | |
Other costs | 285 | 74 | |
Personnel costs | 71,489 | 55,792 |
The increase in personnel costs in the period ended 30 September 2020 compared to the period of the previous financial year is mainly due to the increase in turnover achieved in the Health & Safety and
27
Healthcare & Life Sciences divisions.
6.5 Service costs
The table below breaks down service costs in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2020 | 2019 | ||
Utilities and cleaning services | 4,665 | 4,363 | |
Maintenance | 2,672 | 2,316 | |
Transportation | 4,038 | 2,018 | |
Consulting services | 6,570 | 1,780 | |
Travel and lodging | 631 | 1,394 | |
Subcontracting | 1,480 | 993 | |
Marketing and trade fairs | 577 | 830 | |
Insurance | 785 | 737 | |
Cafeteria | 870 | 733 | |
Commissions | 635 | 444 | |
Directors' fees | 601 | 289 | |
Independent auditor's fees | 371 | 256 | |
Other services | 1,912 | 1,264 | |
Service costs | 25,807 | 17,417 |
Consultancy services, in the period ended 30 September 2020, include, for Euro 4,285 thousand, costs relating to the listing of GVS ordinary shares on the Mercato Telematico Azionario organised and managed by the Italian Stock Exchange.
6.6 Other operating costs
The table below breaks down other operating costs in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2020 | 2019 | ||
Leasing costs | 890 | 1,031 | |
Indirect taxation | 697 | 827 | |
Membership fees and charity contributions | 165 | 104 | |
Losses on sales | - | 40 | |
Other minor costs | 409 | 809 | |
Other operating costs | 2,161 | 2,811 |
Leasing costs include: (i) leasing fees for properties of modest value, for which the Group avails itself of the exemption permitted under IFRS 16, (ii) variable components of a number of leasing fees and
- costs connected with use of property under leasing agreements not subject to IFRS 16.
6.7 Amortisation, depreciation and writedowns
The table below breaks down amortisation, depreciation and writedowns in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro)
20202019
28
Amortisation and writedowns of intangible assets | 4,302 | 4,094 |
Depreciation and writedowns of tangible assets | 6,857 | 6,070 |
Amortisation and writedowns of assets represented by usage rights | 2,799 | 1,821 |
Amortisation, depreciation and writedowns | 13,958 | 11,985 |
6.8 Financial proceeds and charges
The table below breaks down financial proceeds in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Net profits on exchanges | - | 4,864 | |
Other financial proceeds | 94 | 78 | |
Financial proceeds | 94 | 4,942 | |
The table below breaks down financial charges in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Interest on bonded loans | 1,761 | 2,096 | |
Interest on loans | 770 | 1,328 | |
Net losses on exchanges | 6,295 | - | |
Interest on leasing liabilities | 204 | 102 | |
Amortised cost | 116 | 119 | |
Other financial charges | 143 | 59 | |
Financial charges | 9,289 | 3,704 | |
6.9 Annual income tax
The table below breaks down annual income tax in the periods ending on 30 September 2019 and 2020.
The 9-month period closed on 30th September
(in thousands of Euro) | |||
2019 | |||
2020 | |||
Current taxes | 18,691 | 6,783 | |
Deferred taxes | (728) | 2,331 | |
Taxes pertaining to previous financial years | (95) | 1 | |
Income tax | 17,868 | 9,115 | |
In accordance with the provisions of IAS 34, income taxes are recognised on the basis of management's estimate of the weighted average expected annual effective tax rate for the entire year, equal to 23.8% for the period ended 30 September 2020 (25.5% for the period ended 30 September 2019).
29
6.10 Net profit per share
The table below reports net profit per share, calculated as the ratio between net profit and the weighted average number of ordinary shares in circulation in the period, excluding treasury shares.
The 9-month period closed on 30th September | ||
2020 | 2019 | |
Group's share of net profit (in thousands of Euro) | 57,216 | 26,579 |
Weighted average number of shares in circulation | 125,202,104 | 125,202,104 |
Profit per share (in Euro) | 0.46 | 0.21 |
Diluted earnings per share at 30 September was positive at 0.45 (positive at €0.21 at 30 September 2019) calculated by dividing the result attributable to the shareholders of GVS SpA by the weighted average number of shares in circulation, adjusted to take into account the effects of all potential ordinary shares with dilutive effect. As potential ordinary shares with dilutive effect, those linked to the performance shares plan have been considered.
7. Non-recurring revenues and operating costs
Non-recurrent proceeds and charges in the period ending on 30 September 2020 represent: (i) amortisation of intangible assets recorded following the purchase price allocation of the Kuss group (Euro 2,920 thousand), (ii) consultancy costs and one-off bonuses paid to personnel in relation to the IPO procedure concluded on 19 June 2020 (Euro 5,081 thousand), (iii) consultancy costs for purchase of the shareholding in Puerto Rico (Euro 259 thousand) and (iv) personnel reorganisation costs (Euro 284 thousand), net of the related tax effect.
Non-recurrent proceeds and charges in the period ending on 30 September 2019 represent: (i) amortisation of intangible assets entered following purchase price allocation of the Kuss Group (Euro 2,924 thousand), (ii) capital gains resulting from disposal of the real estate assets mentioned above (Euro 254 thousand), (iii) start-up costs incurred for the company established in Mexico (Euro 235 thousand), (iv) tax credits on indirect taxes of the company IOP (China) Filter Co. Ltd., written down following winding-up of the company (Euro 144 thousand), and (v) personnel reorganisation costs (Euro 147 thousand), net of the effect of taxation.
8. Additional information
Economic transactions between group companies are carried out at market prices and are eliminated in the consolidation process. Transactions carried out by Group companies with related parties, which according to IAS 24 are companies and persons able to exercise control, joint control or significant influence over the Group and its subsidiaries, are part of the ordinary course of business and are settled at market conditions. With reference to the provisions of Art. 150, 1st paragraph of Legislative Decree no. 58 of 24 February 1998, no transactions potentially in conflict of interest with Group companies were carried out by members of the Board of Directors.
30
ATTACHED TABLES
Consolidated statement of financial position, with indication of the amounts of positions with related parties.
of which with | At 31 | of which | ||||
(in thousands of Euro) | At 30 September 2020 | percentage | with related | percentage | ||
related parties | December 2019 | |||||
parties | ||||||
ASSETS | ||||||
Non-current assets | ||||||
Intangible assets | 94,486 | 99,846 | ||||
Assets represented by usage rights | 8,757 | 3,186 | 36.4% | 10,320 | 3,899 | 37.8% |
Tangible assets | 67,295 | 46,614 | ||||
Advance tax assets | 2,840 | 1,451 | ||||
Non-current financial assets | 929 | 542 | ||||
Total non-current assets | 174,307 | 158,773 | ||||
Current assets | ||||||
Inventories | 46,017 | 31,491 | ||||
Trade receivables | 66,120 | 35,158 | ||||
Assets from contracts with customers | 1,631 | 591 | ||||
Current tax receivables | 256 | 193 | ||||
Other receivables and current assets | 9,486 | 182 | 1.9% | 6,430 | 515 | 8.0% |
Current financial assets | 4,182 | 3,576 | ||||
Cash on hand | 112,189 | 58,542 | ||||
Total current assets | 239,881 | 135,981 | ||||
TOTAL ASSETS | 414,188 | 294,754 | ||||
SHAREHOLDERS' EQUITY AND LIABILITIES | ||||||
Share capital | 1,750 | 1,650 | ||||
Reserves | 165,003 | 59,489 | ||||
Net income | 57,216 | 33,083 | ||||
Group net shareholders' equity | 223,970 | 94,222 | ||||
Minority interests | 22 | 18 | ||||
Total shareholders' equity | 223,992 | 94,240 | ||||
Non-current liabilities | ||||||
Non-current financial liabilities | 81,373 | 117,638 | ||||
Non-current leasing liabilities | 5,836 | 2,240 | 38.4% | 7,850 | 3,130 | 39.9% |
Deferred tax liabilities | 2,194 | 819 | ||||
Provisions for employee benefits | 4,271 | 1,516 | 35.5% | 4,193 | 1,474 | 35.2% |
Total non-current liabilities | 93,674 | 130,500 | ||||
Current liabilities | ||||||
Current financial liabilities | 26,915 | 36,669 | ||||
Current leasing liabilities | 3,444 | 965 | 28.0% | 3,094 | 982 | 31.7% |
Trade payables | 31,940 | (0) | 0.0% | 13,188 | 31 | 0.2% |
Liabilities from contracts with customers | 4,673 | 1,702 | ||||
Current tax payables | 14,205 | 3,767 | 26.5% | 2,060 | 555 | 26.9% |
Other current payables and liabilities | 15,345 | 936 | 6.1% | 13,301 | 1,883 | 14.2% |
Total current liabilities | 96,522 | 70,014 | ||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 414,188 | 294,754 | ||||
31
Consolidated income statement, with indication of the amounts of positions with related parties.
Period ending on 30 September | ||||||
of | of | |||||
(in thousands of Euro) | 2020 | which | percentage | 2019 | which | percentage |
with | with | |||||
related | related | |||||
parties | parties | |||||
Revenue from customer contracts | 258,170 | 172,625 | ||||
Other revenues and proceeds | 1,150 | 2,058 | ||||
Total revenues | 259,320 | 174,683 | ||||
Purchases and consumption of raw materials, semi-products and finished products | (61,433) | (52,013) | ||||
Personnel costs | (71,489) | (2,533) | 3.5% | (55,792) | (1,784) | 3.2% |
Service costs | (25,807) | (17,417) | ||||
Other operating costs | (2,161) | (2,811) | ||||
EBITDA | 98,430 | 46,651 | ||||
Net writedowns of financial assets | (181) | (207) | ||||
Amortisation, depreciation and writedowns | (13,958) | (685) | 4.9% | (11,985) | (429) | 3.6% |
EBIT | 84,291 | 34,459 | ||||
Financial proceeds | 94 | 4,942 | ||||
Financial charges | (9,289) | (41) | 0.4% | (3,704) | (24) | 0.6% |
Pre-tax result | 75,096 | 35,697 | ||||
Income tax | (17,868) | (9,115) | ||||
Net income | 57,228 | 26,582 | ||||
Group's share | 57,216 | 26,579 | ||||
Minority share | 12 | 3 | ||||
32
Consolidated statement of cash flows, with indication of the amounts of positions with related parties.
Period ending on 30 September | ||||||
(in thousands of Euro) | of which with | of which | ||||
2020 | percentage | 2019 | with related | percentage | ||
related parties | ||||||
parties | ||||||
Pre-tax result | 75,096 | (3,259) | -4% | 35,697 | (2,237) | -6% |
- Adjustment for: | ||||||
Amortisation, depreciation and writedowns | 13,958 | 685 | 5% | 11,985 | 429 | 4% |
Capital losses / (capital gains) from sale of assets | (10) | (214) | ||||
Financial charges / (proceeds) | 9,195 | 41 | 0% | (1,238) | 24 | -2% |
Other non-monetary variations | 1,148 | 42 | 4% | 908 | 27 | 3% |
Cash flow generated / (absorbed) by operations | 99,387 | 47,138 | ||||
before variations in net working capital | ||||||
Variation in inventories | (16,590) | (1,597) | ||||
Variation in trade receivables | (27,352) | (1,084) | 0 | 0% | ||
Variation in trade payables | 25,963 | (31) | 0% | (2,676) | 0 | 0% |
Variation in other assets and liabilities | (2,770) | 1,067 | -39% | (2,063) | 9,054 | -439% |
Use of provisions for risks and charges and for | (644) | (635) | ||||
employee benefits | ||||||
Taxes paid | (6,630) | 971 | -15% | (5,956) | (2,490) | 42% |
Net cash flow generated / (absorbed) by operations | 71,364 | 33,128 | ||||
Investments in tangible assets | (22,176) | (7,689) | ||||
Investments in intangible assets | (2,285) | (2,115) | ||||
Disposal of tangible assets | 196 | 2,847 | ||||
Investment in financial assets | (3,061) | (1,965) | ||||
Disinvestment in financial assets | - | 1,700 | ||||
Payment for purchase of business unit net of cash on | (10,532) | - | ||||
hand acquired | ||||||
Net cash flow generated / (absorbed) by | ||||||
investment | (37,858) | (7,222) | ||||
Opening of long-term financial payables | 503 | 6,500 | ||||
Repayment of long-term financial payables | (41,955) | (22,982) | ||||
Variations in current financial payables | (3,000) | - | ||||
Opening of leasing payables | 1,666 | 0 | ||||
Repayment of leasing liabilities | (3,831) | (879) | 23% | (1,671) | (425) | 25% |
Financial charges paid | (4,018) | (41) | 1% | (4,184) | (24) | 1% |
Financial proceeds collected | 94 | 78 | ||||
Net fee for IPO | 74,508 | - | ||||
Dividends paid | (1,681) | (1,681) | 100% | (7,814) | (7,814) | 100% |
Net cash flow generated/(absorbed) by financial | ||||||
assets | 22,286 | (30,073) | ||||
Total variation in cash on hand | 55,792 | (4,168) | ||||
Cash on hand at the start of the year | 58,542 | 45,551 | ||||
Total variation in cash on hand | 55,792 | (4,168) | ||||
Conversion differences on cash on hand | (2,145) | 1,074 | ||||
Cash on hand at the end of the year | 112,189 | 42,457 | ||||
33
Consolidated income statement, with indication of the amounts deriving from non- recurring transactions.
The 9-month period closed on 30th September | ||||||||
(in thousands of Euro) | of which | 2020 from | of which | 2019 from | ||||
2020 | non- | ordinary | percentag | 2019 | non- | ordinary | percentag | |
recurrin | operation | e | recurrin | operation | e | |||
g | s | g | s | |||||
Revenue from customer contracts | 258,170 | 258,170 | 172,625 | 172,625 | ||||
Other revenues and proceeds | 1,150 | 1,150 | 2,058 | 254 | 1,804 | |||
Total revenues | 259,320 | - | 259,320 | 174,683 | 254 | 174,429 |
Purchases and consumption of raw materials, semi-products and finished products
Personnel costs
Service costs
Other operating costs
(61,433 | (61,433) | (52,013 | (52,013) | ||||
) | ) | ||||||
(71,489 | (1,080) | (70,409) | 1.5% | (55,792 | (147) | (55,645) | 0.3% |
) | ) | ||||||
(25,807 | (4,544) | (21,263) | 17.6% | (17,417 | (235) | (17,182) | 1.3% |
) | ) | ||||||
(2,161) | (2,161) | (2,811) | (144) | (2,667) |
EBITDA | 98,430 | (5,624) | 104,054 | 46,651 | (272) | 46,923 | ||
Net writedowns of financial assets | (181) | (181) | (207) | (207) | ||||
Amortisation, depreciation and writedowns | (13,958 | (2,920) | (11,038) | 20.9% | (11,985 | (2,924) | (9,061) | 24.4% |
) | ) | |||||||
EBIT | 84,291 | (8,544) | 92,835 | 34,459 | (3,196) | 37,655 | ||
Financial proceeds | 94 | 94 | 4,942 | 4,942 | ||||
Financial charges | (9,289) | (9,289) | (3,704) | (3,704) | ||||
Pre-tax result | 75,096 | (8,544) | 83,640 | 35,697 | (3,196) | 38,893 | ||
Income tax | (17,868 | 1,840 | (19,708) | -10.3% | (9,115) | 355 | (9,470) | -3.9% |
) | ||||||||
Net income | 57,228 | (6,704) | 63,932 | 26,582 | (2,841) | 29,423 | ||
34
DECLARATION OF THE MANAGER RESPONSIBLE FOR THE PREPARATION OF THE COMPANY'S ACCOUNTING DOCUMENTS PURSUANT TO ARTICLE 154-BIS PARAGRAPH 2 OF LEGISLATIVE DECREE 58/98
The Manager responsible for the preparation of the Company's financial reports, Mr. Emanuele Stanco, hereby declares, pursuant to paragraph 2 of Article 154 bis of the Consolidated Law on Finance, that the accounting information contained in these Consolidated Interim Financial Statements corresponds to the results of documents, accounting books and entries.
Zola Predosa, 05 November 2020
Emanuele Stanco
Manager responsible for the preparation of the Company's accounting documents
35
GVS S.p.A
Via Roma 50
40069 Zola Predosa (BO) - Italy
www.gvs.com
Attachments
- Original document
- Permalink
Disclaimer
GVS S.p.A. published this content on 14 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 November 2020 16:44:01 UTC